- Home
- STM vs BNTX Comparison
STM vs BNTX Comparison
Compare STM & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STM | BNTX |
|---|---|---|
| Founded | 1987 | 2008 |
| Country | Netherlands | Germany |
| Employees | 49602 | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.9B | 22.8B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | STM | BNTX |
|---|---|---|
| Price | $35.68 | $89.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 13 |
| Target Price | $34.25 | ★ $133.38 |
| AVG Volume (30 Days) | ★ 8.2M | 1.3M |
| Earning Date | 04-23-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.90% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.63 | N/A |
| Revenue Next Year | $12.36 | $4.98 |
| P/E Ratio | $187.61 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.29 | $79.81 |
| 52 Week High | $36.45 | $124.00 |
Technical Indicators
Market Signals| Indicator | STM | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 60.92 | 44.12 |
| Support Level | $24.94 | $84.78 |
| Resistance Level | N/A | $114.06 |
| Average True Range (ATR) | 1.39 | 2.43 |
| MACD | 0.27 | 0.90 |
| Stochastic Oscillator | 86.34 | 59.90 |
Price Performance
Historical ComparisonAbout STM STMicroelectronics N.V.
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconducteurs in France formed STMicroelectronics in 1987. STMicroelectronics is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. It is an especially prominent chip supplier to the industrial and automotive industries.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.